mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.3 |
0.009 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |